Study Details
Eichner, J., Salaway, J., Smith-Jones, J., McCall, R. (2015). "Evaluation of Seventeen Days in Ohio, Pennsylvania, and West Virginia: Findings from the Replication of an Evidence-Based Teen Pregnancy Prevention Program." Pittsburgh, PA: University of Pittsburgh, Office of Child Development.
Downs, J. S., Ashcraft, A. M., Murray, P. J. (2016). Video for adolescent pregnancy prevention: Promises, challenges, and future directions. American Journal of Public Health, 106, S29-S31. doi:10.2105/AJPH.2016.303428
Seventeen Days (formerly What Could You Do?)
Program Information
Evaluation Setting
Study Sample
Research Design
1317
2
6
Study Findings
A more recent study evaluated the program using a randomized controlled trial that involved 1,317 young women who sought treatment at health clinics in Ohio, Pennsylvania, and West Virginia. The young women participating in the study were randomly assigned to either a treatment group that watched a 2.5 hours video with the Seventeen Days program content, or to a control group that watched a video providing information on how to reduce driving risks, the Driving Skills for Life video. The study administered surveys immediately before random assignment (baseline), and again three and six months after the baseline. Three and six months after the baseline, the study found no evidence of statistically significant program impacts on rates of abstinence, defined as not having vaginal sex in the last three months, and on rates of safe sexual behavior, defined as either abstaining from vaginal sex or as having sex using a condom every time in the last three months. The study also examined program impacts on measures of pregnancy and having an STI. Findings for those outcomes were not considered for the review because they did not meet the review standards. Specifically, attrition for the sample on which those outcomes were measured was high and therefore those findings received a Moderate rating. That rating is not consistent with the overall rating of the study (High). Attrition was assessed separately for the pregnancy and STI tests because they were administered in a different data collection effort—vaginal swab tests kits—than the surveys used to measure abstinence and contraceptive use at the 3- and 6
NA = Not available. This means the authors did not report the information in the manuscripts associated with the studies we reviewed.
a This information was not available whenever authors did not report information for the treatment and comparison groups separately on outcome means, standard deviations, and/or sample sizes.
b Authors reported that the program effect (impact) estimate is statistically significant with a p-value of less than 0.05 based on a two-tailed test.
c For some outcomes, having less of that outcome is favorable. In those cases, an effect with a negative sign is favorable to the treatment group (that is, the treatment group had a more favorable outcome than the comparison group, on average).
d An effect shows credibly estimated, statistically significant evidence whenever it has a p-value of less than 0.05 based on a two-tailed test, includes the appropriate adjustment for clustering (if applicable), and it is not based on an endogenous subgroup.